Drug Policy of 1986

A note on the long-awaited Draft National Pharmaceutical Policy 2006. The Policy appears to have taken into consideration consumer needs, paying respect to rational therapeutics. A closer examination of the details---which is what policy critique should do—shows a patchy effort that may...

The paper undertakes a detailed mapping out of the sectoral system of innovation of India's pharmaceutical industry. The industry is one of the most innovative industries in the Indian manufacturing sector. The innovation system of the industry has three strong pillars: very pro active...

Three important aspects of the Canadian pharmaceutical industry-viz. compulsory licence, price control on patented drugs and the R&D scenario. Unlike other developed countries, which have adopted the route of providing higher Intellectual Property Rights (IPR) protection to promote the growth of...

The political economy of the pharmaceutical industry defines truth significantly, if not substantially and wholly, in medicine as much as does dominant medical practice. This mediated wisdom of medicine is purveyed across populations through public health policies affecting millions as is seen...

Access to essential drugs is vital for the promotion of better health for the entire population. High prices of drugs are being used as an argument for greater government role in the drugs sector through effective regulation of the drug market. The high prices of drugs in the Philippines will...

A SWOT analysis of the Indian Pharmaceutical Industry (IPI) in the WTO regime reveals that the much acclaimed IPI’s expertise in process development skills were made possible by the amendments made to the Indian Patents Act 1970. This strength should be utilized maximum to benefit from...